Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.

vcaonline.com September 22, 2021

Frazier Healthcare Partners Adds Highly Experienced Biopharmaceutical Executive To Life Sciences Team

List of Venture Capital / Private Equity Firms and Sources Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory 2021 NEW EDITION NOW AVAILABLE! Buy Now for $119.95 with a free annual update in January 2022 Learn More or Buy Now VCPro Database 2021 24th Edition -- a downloadable and searchable venture capital database with 6,500+ venture capital and private equity firms worldwide.
Read by 48% of LPs

vcaonline.com September 01, 2021

Ars Pharmaceuticals Raises $55M In Series D Funding For Launch Preparations Of Neffy(tm) (epinephrine Nasal Spray)

List of Venture Capital / Private Equity Firms and Sources Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory VCPro Database 2021 24th Edition -- a downloadable and searchable venture capital database with 6,500+ venture capital and private equity firms worldwide.
Read by 52% of LPs

prnewswire.com August 18, 2021

Bridgebio Pharma, Inc. Appoints Finance And Pharmaceutical Leaders Fred Hassan, Andrea Ellis And Douglas Dachille To Its Board Of Directors

PALO ALTO, Calif., Aug. 18, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company founded to discover, create, test and deliver meaningful medicines for patients with genetic diseases and cancers with clear genetic drivers, today...
Read by 77% of LPs

chinamoneynetwork.com August 13, 2021

China Money Podcast: Big Chinese Vc Investments In Pharmaceuticals, E-commerce And Aerospace This Week - China Money Network

In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending August 13. There were 86 deals this week where Chinese startups raised US$2.02 billion. And there were over 320 venture capital and private equity firms that got involved in those [...] China Money Podcast: Big Chinese VC Investments In Pharmaceuticals, E-Commerce And Aerospace This Week comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.
Read by 74% of LPs

vcaonline.com July 20, 2021

Rivus Pharmaceuticals Launches With $35M Series A Financing To Develop Novel Treatments For Cardio-metabolic Diseases

List of Venture Capital / Private Equity Firms and Sources Published since 1998, VCPro Database is the most reliable, up-to-date and affordable venture capital directory VCPro Database 2021 24th Edition -- a downloadable and searchable venture capital database with 6,500+ venture capital and private equity firms worldwide.
Read by 57% of LPs

prnewswire.com May 09, 2021

Alebund Pharmaceuticals Raises $60M In Series B Financing Round To Accelerate Its Development Of Innovative Drugs And Total Solutions For The Treatment Of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its...
Read by 64% of LPs

fiercebiotech.com March 18, 2021

Aktis Bags $72M In Novartis, Bms-backed Series A To Unlock Power Of Radiopharmaceuticals | Fiercebiotech

Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals ntaylor Thu, 03/18/2021 - 08:52.: Aktis Oncology has raised a $72 million series A round to develop radiopharmaceutical treatments for solid tumors. The MPM Capital-founded biotech received investment from Novartis and Bristol Myers Squibb. Nuclear medicine began decades ago with the use of beta emitters such as radioactive iodine. Such drugs achieved some success but failed in microscopic and disseminated cancers, potentially because of their relatively long particle path length and low linear energy transfer.
Read by 40% of LPs

prnewswire.com February 22, 2021

Clover Biopharmaceuticals Raises $230M In Oversubscribed Series C Financing

Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 22, 2021...
Read by 56% of LPs

vcnewsdaily.com January 06, 2021

Terns Pharmaceuticals Raises $87M In Series C

FOSTER CITY, CA, Terns Pharmaceuticals has closed an $87 million Series C financing led by Deerfield Management Company.
Read by 51% of LPs

vcnewsdaily.com December 09, 2020

Reneo Pharmaceuticals Raises $95M In Series B

SAN DIEGO, CA, Reneo Pharmaceuticals has raised $95 million in a Series B financing co-led by Novo Ventures and Abingworth.
Read by 36% of LPs